Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4Gastritis, Atrophic 2Carcinoma, Hepatocellular 2Barrett Esophagus 2Stomach Ulcer 1Lymphoma, Mantle-Cell 1Gastrointestinal Neoplasms 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis 1Fibrosis 1Colorectal Neoplasms 1Cholangiocarcinoma 1Adenomatous Polyposis Coli 1Adenocarcinoma Of Esophagus 1

Interventions

Bevacizumab 77Fluorouracil 55Cetuximab 48Oxaliplatin 43Leucovorin 42pembrolizumab 37Irinotecan 33Folfox protocol 24Capecitabine 24HMPL-013 22Specimen Handling 19trifluridine tipiracil drug combination 17Panitumumab 15Blood Specimen Collection 15Nivolumab 14Magnetic Resonance Spectroscopy 14regorafenib 13Biopsy 13Trifluridine 12Gemcitabine 12Cisplatin 12Standard of Care 11sintilimab 10Interviews as Topic 10IFL protocol 10Drug Therapy 10Carboplatin 10Cyclophosphamide 9tislelizumab 8Trastuzumab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Colorectal Neoplasms × Endoscopy, Digestive System × Clear all
NCT06557733 2026-05-13

An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Recruiting
38 enrolled
Gastrointestinal

Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡